MIT Biotechnology Group

Longevity accelerator

AGE1 is a three-month, longevity-focused biotech accelerator based in San Francisco offering up to $500k in funding, mentorship from leaders in bio, and introductions to 50+ investors, pharma partners, and members of the press. We’re looking to back talented grad students and other young entrepreneurs, so apply now for Batch III.

Leave a Reply